BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32799103)

  • 1. Nullifying epigenetic writer DOT1L attenuates neointimal hyperplasia.
    Huang Y; Urabe G; Zhang M; Li J; Ozer HG; Wang B; Kent KC; Guo LW
    Atherosclerosis; 2020 Sep; 308():22-31. PubMed ID: 32799103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neointima abating and endothelium preserving - An adventitia-localized nanoformulation to inhibit the epigenetic writer DOT1L.
    Shirasu T; Yodsanit N; Li J; Huang Y; Xie X; Tang R; Wang Q; Zhang M; Urabe G; Webb A; Wang Y; Wang X; Xie R; Wang B; Kent KC; Gong S; Guo LW
    Biomaterials; 2023 Oct; 301():122245. PubMed ID: 37467597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer.
    Yang L; Lei Q; Li L; Yang J; Dong Z; Cui H
    Clin Epigenetics; 2019 Dec; 11(1):199. PubMed ID: 31888761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyltransferase Dot1l preferentially promotes innate IL-6 and IFN-β production by mediating H3K79me2/3 methylation in macrophages.
    Chen X; Liu X; Zhang Y; Huai W; Zhou Q; Xu S; Chen X; Li N; Cao X
    Cell Mol Immunol; 2020 Jan; 17(1):76-84. PubMed ID: 30275539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis.
    Yang D; Xu P; Su H; Zhong W; Xu J; Su Z; Liu X
    Cell Death Dis; 2022 Jan; 13(1):60. PubMed ID: 35039472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking the histone lysine 79 methyltransferase DOT1L alleviates renal fibrosis through inhibition of renal fibroblast activation and epithelial-mesenchymal transition.
    Liu L; Zou J; Guan Y; Zhang Y; Zhang W; Zhou X; Xiong C; Tolbert E; Zhao TC; Bayliss G; Zhuang S
    FASEB J; 2019 Nov; 33(11):11941-11958. PubMed ID: 31373855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-24 Attenuates Neointimal Hyperplasia in the Diabetic Rat Carotid Artery Injury Model by Inhibiting Wnt4 Signaling Pathway.
    Yang J; Fan Z; Yang J; Ding J; Yang C; Chen L
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of DOT1L in the proliferation and prognosis of gastric cancer.
    Song Z; Wei Z; Wang Q; Zhang X; Tao X; Wu N; Liu X; Qian J
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31939604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epigenetic enzyme DOT1L orchestrates vascular smooth muscle cell-monocyte crosstalk and protects against atherosclerosis via the NF-κB pathway.
    Farina FM; Serio S; Hall IF; Zani S; Cassanmagnago GA; Climent M; Civilini E; Condorelli G; Quintavalle M; Elia L
    Eur Heart J; 2022 Nov; 43(43):4562-4576. PubMed ID: 35292818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DOT1L Regulates Thermogenic Adipocyte Differentiation and Function via Modulating H3K79 Methylation.
    Shuai L; Li BH; Jiang HW; Yang L; Li J; Li JY
    Diabetes; 2021 Jun; 70(6):1317-1333. PubMed ID: 33795413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angioplasty induces epigenomic remodeling in injured arteries.
    Zhang M; Urabe G; Ozer HG; Xie X; Webb A; Shirasu T; Li J; Han R; Kent KC; Wang B; Guo LW
    Life Sci Alliance; 2022 May; 5(5):. PubMed ID: 35169042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone Demethylase JMJD2A Inhibition Attenuates Neointimal Hyperplasia in the Carotid Arteries of Balloon-Injured Diabetic Rats via Transcriptional Silencing: Inflammatory Gene Expression in Vascular Smooth Muscle Cells.
    Qi H; Jing Z; Xiaolin W; Changwu X; Xiaorong H; Jian Y; Jing C; Hong J
    Cell Physiol Biochem; 2015; 37(2):719-34. PubMed ID: 26356263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted disruption of the histone lysine 79 methyltransferase Dot1L in nephron progenitors causes congenital renal dysplasia.
    Wang F; Ngo J; Li Y; Liu H; Chen CH; Saifudeen Z; Sequeira-Lopez MLS; El-Dahr SS
    Epigenetics; 2021 Nov; 16(11):1235-1250. PubMed ID: 33315499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate deficiency reduced aberrant level of DOT1L-mediated histone H3K79 methylation causes disruptive SHH gene expression involved in neural tube defects.
    Li X; Pei P; Shen J; Yu J; Wang F; Wang L; Liu C; Wang S
    Epigenetics Chromatin; 2023 Dec; 16(1):50. PubMed ID: 38093377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DOT1L-MLLT10 complex regulates male fertility and promotes histone removal during spermiogenesis.
    Lin H; Cossu IG; Leu NA; Deshpande AJ; Bernt KM; Luo M; Wang PJ
    Development; 2023 May; 150(9):. PubMed ID: 37082953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of histone methyltransferase DOT1L plays a dual role in chemosensitization of retinoblastoma cells and enhances the efficacy of chemotherapy.
    Mao Y; Sun Y; Wu Z; Zheng J; Zhang J; Zeng J; Lee C; Kim JK
    Cell Death Dis; 2021 Dec; 12(12):1141. PubMed ID: 34887387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsiveness.
    Kari V; Raul SK; Henck JM; Kitz J; Kramer F; Kosinsky RL; Übelmesser N; Mansour WY; Eggert J; Spitzner M; Najafova Z; Bastians H; Grade M; Gaedcke J; Wegwitz F; Johnsen SA
    Clin Epigenetics; 2019 Jan; 11(1):4. PubMed ID: 30616689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of DOT1L localization and H3K79 methylation during meiotic prophase I in mouse spermatocytes.
    Ontoso D; Kauppi L; Keeney S; San-Segundo PA
    Chromosoma; 2014 Mar; 123(1-2):147-64. PubMed ID: 24105599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Disruptor of Telomeric Silencing 1-Like Alleviated Renal Ischemia and Reperfusion Injury-Induced Fibrosis by Blocking PI3K/AKT-Mediated Oxidative Stress.
    Yang C; Chen Z; Yu H; Liu X
    Drug Des Devel Ther; 2019; 13():4375-4387. PubMed ID: 31920287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.
    Chen CW; Koche RP; Sinha AU; Deshpande AJ; Zhu N; Eng R; Doench JG; Xu H; Chu SH; Qi J; Wang X; Delaney C; Bernt KM; Root DE; Hahn WC; Bradner JE; Armstrong SA
    Nat Med; 2015 Apr; 21(4):335-43. PubMed ID: 25822366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.